O3b Networks Earns Via Satellite “Satellite Operator of the Year” Award at SATELLITE 2016
O3b Networks today announced that the company has been recognized as “Satellite Operator of the Year” in the 2015 Via Satellite Excellence Awards during SATELLITE 2016.
The Via Satellite Excellence Awards recognize innovative companies, technologies, campaigns, and people who shape the success of the global satellite industry. The Operator of the Year Award recognizes the satellite operator that made a significant impact in 2015 and plays a key role in keeping the industry thriving.
O3b Networks has dramatically broadened the satellite market, providing modern high-performance connectivity to areas that had previously thought such service was only possible with terrestrial fiber. To date, the company has 12 satellites in orbit that provide service to more than 40 customers in 31 countries. Recently, O3b ordered 8 more satellites to support growing demand.
The ultra-low latency, high throughput network, facilitated by O3b's Medium Earth Orbit (MEO) satellite constellation provides connectivity to Mobile Network Operators (MNOs) to expand 3G and 4G/LTE services, enables Internet Service Providers (ISPs) to provide broadband internet to subscribers in remote locations, brings high-speed mobile and data connections to ships at sea, and allows Oil and Gas companies to reduce costs and improve efficiencies on deep water installations. O3b technology is also used worldwide to enable new business, government, education, and e-health initiatives.
“Today, access to the internet is fundamentally important, and we are proud to support our customers in providing the core connectivity that is driving social and economic development around the globe,” said Steve Collar, CEO of O3b Networks. “As a company, O3b has been fiercely dedicated to providing the best solutions for reliable connectivity in areas of the world that are beyond the reach of fiber. We are honored to be named Operator of the Year, and thank Via Satellite for this distinction.”
About O3b Networks Limited
O3b Networks Limited is a global satellite service provider operating a next-generation satellite network for telecommunications operators, Internet service providers, enterprise and government customers in emerging markets. The O3b system combines the global reach of satellite with the speed of a fiber‐optic network providing billions of consumers and businesses in nearly 180 countries with low‐cost, high‐speed, low latency Internet and mobile connectivity. O3b Networks’ investors include SES, Google, Liberty Global, HSBC Principal Investments, Northbridge Venture Partners, Allen & Company, Development Bank of Southern Africa, Sofina, Satya Capital and Luxempart. O3b Networks is headquartered in St. Helier, Jersey, Channel Islands.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
ADC-THERAPEUTICS11.12.2017 07:32 | pressemeddelelse
ADC Therapeutics Announces Interim Phase I Data from its Novel Antibody-Drug Conjugate ADCT-301
ADC-THERAPEUTICS11.12.2017 07:02 | pressemeddelelse
ADC Therapeutics Presents Interim Phase I Data from its Novel Antibody-Drug Conjugate ADCT-402
FL-GA-TELESIS11.12.2017 06:03 | pressemeddelelse
GA Telesis Launches Leveraged Finance Group with the Appointments of David Lloyd and Nolan Heske
ASTRAZENECA10.12.2017 23:47 | pressemeddelelse
AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials
NJ-CELGENE/BLUEBIRD-BIO10.12.2017 16:32 | pressemeddelelse
Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
GA-GILEAD-SCIENCES/KITE10.12.2017 16:32 | pressemeddelelse
Kite Announces Long-Term Data From Pivotal ZUMA-1 Study of Yescarta™ (Axicabtagene Ciloleucel) in Patients With Refractory Large B-cell Lymphoma
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum